Advanced Search

Study Preview



Study Title and Description

Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.
Author Chan L., Greenstein S., Hardy MA., Hartmann E., Bunnapradist S., Cibrik D., Shaw LM., Munir L., Ulbricht B., Cooper M.
Country Health Sciences Center, University of Colorado, Denver, CO 80262, USA. larry.chan@uchsc.edu
Year 2008
Numbers Pubmed ID: 18360262
2215 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.